Lonza
Lonza is a global contract development and manufacturing organization that provides services and technologies for the pharmaceutical, biotech, and nutrition industries, including custom development and large-scale production of active ingredients and finished dosage forms. The company serves biotech startups, large pharma, and consumer health companies by offering outsourced R&D, manufacturing, and related support services. It generates revenue through long-term manufacturing contracts, development services, and licensing of proprietary technologies.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1897
- Headquarters
- Basel, Switzerland
Lonza customers on Arbolus
Customers who reviewed Lonza
Seniority of Lonza customers
The largest group of people who reviewed Lonza holds C-Suite roles (43%), followed by Director (40%) and Manager (17%).
- C-Suite 43%
- Director 40%
- Manager 17%
Customers sample
Employer names and spend open in the full report, along with the other 68 customers.
What 71 Arbolus experts think of Lonza
Overall sentiment: Positive
NPS distribution shows 45.7% Promoters, 35.7% Passives, and 18.6% Detractors, with an average NPS of 7.99 and a score of 27.1. Renewal intent is positive, with 53.8% likely to renew, 7.7% unlikely, and 38.5% unsure. Stickiness is high, with 70% of customers using Lonza for more than one year. Key feedback themes highlight strong manufacturing quality and regulatory expertise, but concerns about cost and scheduling rigidity persist.
Everything 71 customers told us about Lonza.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
26 Net Promoter Score, from 71 scored reviews- Promoters 32
- Passives 26
- Detractors 13
Praised
- Manufacturing Quality and Regulatory Expertise
- AI-Driven Process Optimization
Criticised
- Premium Pricing and Rigid Scheduling
- Agile Competitors and Commoditization Risk
What Lonza customers say
Manufacturing Quality and Regulatory Expertise
“I gave Lonza a 6 because their manufacturing quality and regulatory track record are virtually bulletproof, which is exactly what you want when scaling complex therapeutics.”
AI-Driven Process Optimization
“If an enterprise AI platform becomes capable of perfectly predicting scale-up parameters and optimizing cell line expression virtually, we could bypass Lonza's expensive developmental services entirely.”
Premium Pricing and Rigid Scheduling
“It misses a 9 or 10 solely because of the steep premium pricing and the rigid, long-lead-time scheduling required to secure a manufacturing slot.”
Renewal intent
Plan to renew 57%Plan to renew, by seniority
- 47% 15 answers
- 68% 19 answers
- 60% 5 answers
- 0% 1 answer
- 8.4/10 Average score from customers who will renew
- 7.6/10 Average score from undecided customers
- 7.3/10 Average score from customers not renewing
Top alternatives
Most weighed by Lonza customersReport
For people who use Lonza
Do you use Lonza at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 71 customers of Lonza have already contributed
Takes a few minutes. Your identity stays anonymous.